MEDHERANT LTD has a total of 31 patent applications. It increased the IP activity by 150.0%. Its first patent ever was published in 2015. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and basic materials chemistry are CONTROLLED THERAPEUTICS SCT, BENTLEY MICHAEL DAVID and CONTROLLED THERAPEUTICS SCOTLAND LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Israel | 2 | |
#5 | Republic of Korea | 2 | |
#6 | United States | 2 | |
#7 | Australia | 1 | |
#8 | Canada | 1 | |
#9 | China | 1 | |
#10 | Mexico | 1 | |
#11 | Philippines | 1 | |
#12 | Russian Federation | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers | |
#3 | Basic materials chemistry | |
#4 | Chemical engineering | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Adhesives | |
#3 | Special macromolecular compounds | |
#4 | Therapeutic chemical compounds | |
#5 | Analysing materials | |
#6 | Mixing | |
#7 | Chemical or physical laboratory devices |
# | Name | Total Patents |
---|---|---|
#1 | Haddleton David | 16 |
#2 | Nikolaou Vasiliki | 6 |
#3 | O'Driscoll Ciaran | 6 |
#4 | Goubard David | 6 |
#5 | Nurumbetov Gabit | 6 |
#6 | Ross Andrew | 5 |
#7 | David Haddleton | 3 |
#8 | David Goubard | 2 |
#9 | Ciaran O'Driscoll | 2 |
#10 | Gubar David | 1 |
Publication | Filing date | Title |
---|---|---|
GB202100993D0 | Patch | |
GB201905338D0 | Patch | |
GB201811833D0 | Patch | |
GB201811834D0 | Patch | |
WO2018203048A1 | Drug delivery composition | |
GB201707035D0 | Drug delivery composition | |
GB201706969D0 | Formulation | |
GB201706968D0 | Drug delivery composition | |
GB201702956D0 | Diffusion test system | |
CN108289831A | Drug delivery composition containing silyl polymer | |
GB201602907D0 | Drug delivery composition | |
GB201519321D0 | Drug delivery system |